CCR3 blockade as a new therapy for asthma
- 1 January 2000
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 9 (1), 43-52
- https://doi.org/10.1517/13543784.9.1.43
Abstract
Among the inflammatory cells infiltrating the lungs of asthmatic patients, eosinophils and Th2 cells are thought to play a central role in the pathogenesis of this disease. Several studies have implicated that chemokines are prime candidates for being responsible for the selective recruitment of the leukocyte subsets found in atopic diseases. Regulated upon activation, normal T-cell-expressed and secreted (RANTES), monocyte chemoattractant protein-3 (MCP-3), MCP-4 and the eotaxins, for example, have been shown in vitro to potently induce eosinophil chemotaxis as well as initiate several other pro-inflammatory activities such as integrin activation, lipid mediator biosynthesis and degranulation. Ligand binding and chemotaxis experiments with these chemokines demonstrated that a G-protein coupled-receptor (GPCR) cloned from eosinophils, termed CCR3, was responsible for producing a chemokine selectivity profile identical to that of eosinophils. In addition, blocking CCR3 on eosinophils, with a monoclonal antibody, completely abolished eosinophil responses to these chemokines. Together these studies strongly suggest a central role for this receptor in eosinophil trafficking. CCR3 has also been found on in vitro derived Th2 cells and on T-cells co-localising with eosinophils in diseased tissue, thus revealing a possible pathogenic mechanism for T-cell recruitment into the airways. Therefore, blockade of CCR3 represents a highly attractive and innovative strategy for asthma therapy.Keywords
This publication has 52 references indexed in Scilit:
- Chemokines and Chemokine Receptors: Biology and Clinical Relevance in Inflammation and AIDSAnnual Review of Medicine, 1999
- Eotaxin and Capping Protein in Experimental VasculopathyThe American Journal of Pathology, 1998
- Chemokines and leukocyte trafficNature, 1998
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids.JCI Insight, 1997
- Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.JCI Insight, 1996
- Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Eotaxin: Cloning of an Eosinophil Chemoattractant Cytokine and Increased mRNA Expression in Allergen-Challenged Guinea-Pig LungsBiochemical and Biophysical Research Communications, 1994
- Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.The Journal of Experimental Medicine, 1994
- The Chemokine, Eotaxin, Activates Guinea-Pig Eosinophils in Vitro and Causes Their Accumulation into the Lung in VivoBiochemical and Biophysical Research Communications, 1993